Aurora Cannabis (TSE:ACB) Shares Down 0.8% – Should You Sell?

Aurora Cannabis Inc. (TSE:ACBGet Free Report) fell 0.8% during mid-day trading on Thursday . The stock traded as low as C$6.26 and last traded at C$6.34. 62,609 shares traded hands during trading, a decline of 84% from the average session volume of 389,808 shares. The stock had previously closed at C$6.39.

Analyst Ratings Changes

A number of research firms recently issued reports on ACB. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. ATB Capital lowered their price target on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th. Three investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of C$5.85.

Check Out Our Latest Report on Aurora Cannabis

Aurora Cannabis Price Performance

The firm has a market cap of C$325.23 million, a P/E ratio of -9.44 and a beta of 2.71. The stock’s 50-day moving average is C$6.40 and its 200-day moving average is C$7.37. The company has a quick ratio of 2.48, a current ratio of 3.76 and a debt-to-equity ratio of 16.95.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.

Featured Articles

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.